Back to search results

Supporting Medtronic 780G Insulin Pump Use in Latino Youth

This study is looking at whether a special support program, offered in Spanish or both English and Spanish, helps Latino youth with Type 1 Diabetes (T1D) successfully use the Medtronic MiniMed 780G insulin pump system. This system is an advanced device that helps deliver insulin automatically. The study wants to see if this tailored program helps more people continue using the pump. You might be able to join if you are 10-20 years old, have Type 1 Diabetes, identify as Latino/Hispanic, and are willing to use the Medtronic MiniMed 780G system. The study plans to enroll 15 participants. We don't know the current recruitment status.

Study design
This is a single-group study, meaning all 15 participants will receive the same intervention. It is an interventional study, focusing on a structured support program.
What's involved
Participants will use the Medtronic MiniMed 780G system for eight months. This includes one in-person nutrition and pump start class, and regular virtual check-ins with Spanish-speaking staff.
Compensation
Not stated in the trial record.
Follow-up
The main goal is to see how many participants are still using the system after 6 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07720388

Supporting Medtronic 780G Insulin Pump Adoption in Latino Patients: A Spanish - Language Training Initiative

Not Yet Recruiting
NAAges 10–20InterventionalTreatment
University of Colorado, Denver
~15 participants
Updated 2026-07-22 on ClinicalTrials.gov
What's tested:Culturally and linguistically tailored onboarding and support programMedtronic MiniMed 780G Insulin Pump System

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Proportion of Participants Continuing Use of the Medtronic MiniMed 780G System at 6 Months
Measured over 6 months

Conditions

Diabetes Mellitus, Type 1 Diabetes

Explore related trials

Type 1 Diabetes Mellitus

Where it's being run

1 sites across 1 states
Colorado1

Who to contact

Study Coordinator
[email protected]
303-724-4315
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age 10 - 20 years old
Diagnosis of type 1 diabetes
Self-identify as Latino/Hispanic (determined via self-report and/or electronic health record)
Currently managing diabetes using any regimen, including multiple daily injections (MDI) or any non-Medtronic automated insulin delivery system
Willing to transition to and use the Medtronic MiniMed 780G system for the duration of the study

Exclusion

Current use of any Medtronic technology
More than 1 episode of diabetic ketoacidosis (DKA) within 12 months of study enrollment
Current pregnancy (self-reported), due to limited safety data for use of the Medtronic MiniMed 780G system during pregnancy
Presence of any significant medical condition that, in the opinion of the investigator, would interfere with study participation or data interpretation
Inability or unwillingness to use the Medtronic MiniMed 780G system for the duration of the study

What this trial measures

  • Proportion of Participants Continuing Use of the Medtronic MiniMed 780G System at 6 Months6 months

    Adoption will be defined as continued use of the Medtronic MiniMed 780G insulin pump system at 6 months following initiation. The outcome will be calculated as the proportion of enrolled participants who remain actively using the system at the 6-month time point.